HI
Humacyte Inc
🇺🇸XNAS.HUMAUnited StatesHealthcare
$0.55USDdown -0.02 (-3.51%)Pre-marketDelayed1:28 PM
Price$0.55-0.02 (-3.51%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US44486Q1031
- CUSIP
- 44486Q103
Company
- Employees
- 184
- Headquarters
- Durham, United States
- Website
- https://www.humacyte.com
- CEO
- Dr. Laura E. Niklason M.D., Ph.D.
Market
- Shares outstanding
- 277.8M
- Market cap
- $152.79M
Highlights
- Market cap
- $152.79M
- EPS LTM
- -$0.41
- P/E LTM
- -2.06
- Div yield
- 0%
Fundamentals (LTM)
- Revenue
- $2.12M-73.64%down year on year
- Net income
- -$96.74M-64.91%down year on year
- Gross margin
- -666.81%-3,646.6%down year on year
- Free cash flow
- -$97.56M+8.21%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.